4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine

Summary

This phase 2 randomized study will be used to test the efficacy of 4-aminopyridine (4AP) or atenolol to reduce severity and frequency of vestibular and headache symptoms of vestibular migriane sufferers. Blinded study drug will be taken by mouth twice a day for 14 weeks on study.

Timeline

Start

2019-01

Primary completion

2023-01

Completion

2024-08

Drugs

Indications